Independence Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-2,700
Closed -$255K 107
2019
Q1
$255K Buy
+2,700
New +$236K 0.07% 77
2017
Q2
Sell
-1,650
Closed -$205K 79
2017
Q1
$205K Buy
+1,650
New +$197K 0.09% 71

Other funds holding CELG

Independence Advisors's CELG Position: Q2 2019 in Review

Independence Advisors sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 2,700 shares — an estimated $255K sold.

Independence Advisors first reported a position in CELG in Q1 2017 and held it in 2 quarters. The position peaked at $255K in Q1 2019. 1,287 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • Independence Advisors reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • Independence Advisors sold 2,700 Celgene Corp shares in Q2 2019, an estimated $255K.
  • Independence Advisors first reported a position in Celgene Corp in Q1 2017 and held it in 2 quarters.
  • Independence Advisors's Celgene Corp position peaked at $255K in Q1 2019.
  • 1,287 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Independence Advisors's 13F filing for Q2 2019, filed 12 Aug 2019.